Required duration of combined annual ivermectin treatment and vector control in the Onchocerciasis Control Programme in West Africa

Bulletin of the World Health Organization

Volumn 75, Issue 3, 1997, Pages 237-245

  Plaisier, A P ^a   Alley, E S ^b   Van Oortmarssen, G J ^a   Boatin, B A ^c   Habbema, J D F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b African Programme for Onchocerciasis Control Ouagadougou   (Burkina Faso)

^c OCP   (Burkina Faso)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

IVERMECTIN; ONCHOCERCIASIS CONTROL; VECTOR CONTROL;

AFRICA; ARTICLE; HUMAN; INFECTION PREVENTION; ONCHOCERCIASIS; SIMULIUM DAMNOSUM; TREATMENT OUTCOME; VECTOR CONTROL;

ADOLESCENT; ADULT; ANIMALS; ANTINEMATODAL AGENTS; BURKINA FASO; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FILARICIDES; HUMANS; INFANT; INSECT CONTROL; IVERMECTIN; MALE; MIDDLE AGED; MODELS, STATISTICAL; ONCHOCERCIASIS; POPULATION SURVEILLANCE; PREVALENCE; PROGRAM EVALUATION; SIMULIIDAE; TIME FACTORS;

AFRICA, (WEST);

EID: 0030803682     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Plaisier AP et al. The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. Bulletin of the World Health Organization, 1991, 69: 169-178.
2. Dadzie KY et al. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. British journal of ophthalmology, 1987, 71: 78-85.
3. Dadzie KY, Remme J, De Sole G. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991, 85: 267-271.
4. Abiose A et al. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet, 1993, 341: 130-134.
5. De Sole G et al. Lack of adverse reactions in ivermectin treatment of onchocerciasis. Lancet, 1990, 335: 1106-1107.
6. De Sole G et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bulletin of the World Health Organization, 1989, 67: 707-719.
7. Strategies for ivermectin distribution through primary health care systems. Report of the Meeting on Strategies for Ivermectin Distribution through Primary Health Care Systems, Geneva, 22-25 April 1991. Geneva, World Health Organization, 1991 (unpublished document WHO/PBL/91.24, available upon request from Programme for the Prevention of Blindness and Deafness, World Health Organization, 1211 Geneva 27, Switzerland).
8. Remme J et al. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. Tropical medicine and parasitology, 1989, 40: 367-374.
9. Cupp EW et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. American journal of tropical medicine and hygiene, 1992, 47: 170-180.
10. Guillet P et al. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea. Bulletin of the World Health Organization, 1995, 73: 199-205.
11. Remme J et al. Large scale ivermectin distribution and its epidemiological consequences. Acta Leidensia, 1990, 59: 177-191.
12. Habbema JDF et al. Epidemiological modelling for onchocerciasis control. Parasitology today, 1992, 8: 99-103.
13. Onchocerciasis control programme in West Africa: mid-term (phase IV) prospective evaluation of the Onchocerciasis Control Programme in West Africa, September 1994. Geneva, World Health Organization, 1995 (unpublished WHO document OCP/JPC/ 95.7, available upon request from Onchocerciasis Control Programme in West Africa, World Health Organization, 1211 Geneva 27, Switzerland).
14. Remme J, De Sole G, van Oortmarssen GJ. The predicted and observed decline in onchocerciasis infection during 14 years of successful control of Simullum spp. in west Africa. Bulletin of the World Health Organization, 1990, 68: 331-339.
15. Plaisier AP et al. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. Journal of infectious diseases, 1995, 172: 204-210.
16. Plaisier AP et al. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Computer methods and programs in biomedicine, 1990, 31: 43-56.
17. Plaisier AP et al. The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta tropica, 1991, 48: 271-284.
18. Habbema JDF, van Oortmarssen GJ, Plaisier AP. The ONCHOSIM model and its use in decision support for river blindness control. In: Isham V, Medley GF, eds. Models for infectious human diseases: their structure and relation to data. Cambridge, Cambridge University Press, 1996.
19. Alley ES et al. The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88: 581-584.
20. Clayton D, Hills M. Statistical models in epidemiology. Oxford, Oxford University Press, 1993.
21. Onchocerciasis control programme in West Africa. Expert Advisory Committee report of the fifteenth session, Ouagadougou, 6-10 June 1994. Geneva, World Health Organization, 1994 (unpublished WHO document OCP/EAC/94.1).
22. McMillan DE. Sahel visions - planned settlement and river blindness control in Burkina Faso. Tuscon, University of Arizona Press, 1995.
23. Garms R et al. Studies on the reinvasion of the Onchocerciasis Control Programme in the Volta River Basin by Simulium damnosum s.l. with emphasis on the southwestern areas. Tropical medicine and parasitology, 1979, 30: 345-362.
24. Philippon B et al. Entomological results of vector control in the Onchocerciasis Control Programme. Acta Leidensia, 1990, 59: 79-94.